94 related articles for article (PubMed ID: 6150627)
21. [Echocardiographic study of patients with hypertrophic obstructive cardiomyopathy during therapy with beta blockers].
Gebauerová M; Niederle P; Jebavý P; Krykorka P; Fabián J; Widimský J
Vnitr Lek; 1984 Jan; 30(1):13-20. PubMed ID: 6141667
[No Abstract] [Full Text] [Related]
22. [beta-Receptor blockers in the early stage of myocardial infarction with left ventricular failure (author's transl)].
Jentsch G
MMW Munch Med Wochenschr; 1981 Mar; 123(11):425-8. PubMed ID: 6783847
[TBL] [Abstract][Full Text] [Related]
23. At the heart of a drug: beta blocker. The Norwegian Multicentre Study Group.
Nurs Mirror; 1981 Apr; 152(18):40. PubMed ID: 7017608
[No Abstract] [Full Text] [Related]
24. [Clinical pharmacology of Metipranolol (trimepranol injection VUFB, Spofa tablets). The importance of clinical dosages].
Mayer O; Cepelák V; Vitous J
Vnitr Lek; 1981 Feb; 27(2):160-71. PubMed ID: 6110280
[No Abstract] [Full Text] [Related]
25. [The effect of betalytics on blood circulation in the extremities of patients with lower extremity ischemic disease].
Spácil J
Cas Lek Cesk; 1987 May; 126(19):600-4. PubMed ID: 2885093
[No Abstract] [Full Text] [Related]
26. [Metoprolol in the treatment of myocardial infarct in the acute stage].
Di Benedetto A; Cipolla A; Badalamenti E; Scilabra G
Boll Soc Ital Cardiol; 1981; 26(7):613-29. PubMed ID: 7347259
[No Abstract] [Full Text] [Related]
27. Benefits of non-selective versus cardioselective beta-blockers in acute myocardial infarction in hypertensive patients.
Hansen O; Johansson BW
J Hypertens Suppl; 1993 Jun; 11(4):S55-60. PubMed ID: 8104242
[TBL] [Abstract][Full Text] [Related]
28. [Intraindividual comparison between 1 tablet BM 02.004 and 1 tablet of torrat twice daily in the long-term treatment of hypertension].
Teufel W; Glocke M; Nagel W
Ther Ggw; 1981 Dec; 120(12):1162-70. PubMed ID: 6120581
[No Abstract] [Full Text] [Related]
29. Effect of acute and long-term beta-adrenergic blockade with alprenolol in definite or suspected myocardial infarction. Salvage of ischaemic myocardium by alprenolol.
Jürgensen HJ; Frederiksen J; Hansen DA; Pedersen-Bjergaard O
Acta Med Scand Suppl; 1984; 680():27-33. PubMed ID: 6375277
[No Abstract] [Full Text] [Related]
30. [Effect of drug therapy of myocardial infarction on the inflammatory process].
Chukaeva II; Orlova NV; Khavka NN
Voen Med Zh; 2007 Jul; 328(7):38-40. PubMed ID: 17902343
[No Abstract] [Full Text] [Related]
31. Impact of acute beta-blocker therapy for patients with non-ST-segment elevation myocardial infarction.
Miller CD; Roe MT; Mulgund J; Hoekstra JW; Santos R; Pollack CV; Ohman EM; Gibler WB; Peterson ED
Am J Med; 2007 Aug; 120(8):685-92. PubMed ID: 17679127
[TBL] [Abstract][Full Text] [Related]
32. [The effect of trimepranol on metabolism in the ischemic heart muscle].
Gvozdják J; Gvozdjáková A; Kucharská J; Bada V; Baranyai A; Drímal J
Vnitr Lek; 1985 Mar; 31(3):209-15. PubMed ID: 2863890
[No Abstract] [Full Text] [Related]
33. [Bolus molsidomine administration for induction of parenteral molsidomine therapy in acute myocardial infarct. Effect on systemic blood pressure].
Klüsener W
Med Klin (Munich); 1994 Jul; 89 Suppl 2():7-9. PubMed ID: 7968912
[No Abstract] [Full Text] [Related]
34. Prognostic impact of acute beta-blocker therapy on top of aspirin and angiotensin-converting enzyme inhibitor therapy in consecutive patients with ST-elevation acute myocardial infarction.
Wienbergen H; Zeymer U; Gitt AK; Juenger C; Schiele R; Heer T; Towae F; Senges J;
Am J Cardiol; 2007 May; 99(9):1208-11. PubMed ID: 17478143
[TBL] [Abstract][Full Text] [Related]
35. [Treatment of essential hypertension with the beta-receptor antagonist carteolol. A multicenter study].
Rosprich G; Sölter H
Arzneimittelforschung; 1983; 33(2a):334-9. PubMed ID: 6682326
[No Abstract] [Full Text] [Related]
36. Impact of nonfatal myocardial infarction on outcomes in patients with advanced heart failure and the effect of bucindolol therapy.
O'Connor CM; Gottlieb S; Bourque JM; Krause-Steinrauf H; Anand I; Anderson JL; Plehn JF; Silver MA; White M; Carson P;
Am J Cardiol; 2005 Mar; 95(5):558-64. PubMed ID: 15721091
[TBL] [Abstract][Full Text] [Related]
37. Prevention of adrenaline-induced metabolic systemic and myocardial alterations by the beta-blocking agent metipranolol in the dog.
Herbaczyńska-Cedro K; Woźniewicz B; Broniszewska-Ardelt B; Ceremuzyński L
Cardiology; 1981; 67(4):206-18. PubMed ID: 6113891
[TBL] [Abstract][Full Text] [Related]
38. [Metipranolol in the treatment of glaucoma. Introductory clinical study (author's transl)].
Dienstbier E; Růzicková E; Cepelík J
Cesk Oftalmol; 1981 Jan; 37(1):5-12. PubMed ID: 6110486
[No Abstract] [Full Text] [Related]
39. Repair of postinfarction ventricular septal defect on a beating heart.
Takahashi T; Kadoba K; Taniguchi K; Sawa Y; Imagawa H; Masai T; Matsuda H
Ann Thorac Surg; 1996 Jun; 61(6):1816-7. PubMed ID: 8651790
[TBL] [Abstract][Full Text] [Related]
40. The role of digitalis in acute myocardial infarction.
Liberman HA
Prim Care; 1981 Sep; 8(3):483-90. PubMed ID: 6914672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
